Specifically, Hao et al. (2016) demonstrated that mutant PIK3CA upregulates the enzyme glutamate pyruvate transaminase 2 (GPT2), increasing glutamine utilization to support tumor growth. This evidence concerns the gene GPT2 and neoplasm.